Bio Medica Laboratories Peer Comparison

NSE: BMLL

₹166.00

₹1.50 (0.91%)

As on 28-Sep-2026IST

Market cap

₹207 Cr

Revenue (TTM)

₹38 Cr

P/E Ratio

17.2

P/B Ratio

--

Div. Yield

0 %

Edit

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Market cap (₹ Cr)	207	7,649	145	142	33
Revenue (₹ Cr)	38	7,128	58	107	13
Net Profit (₹ Cr)	9.79	167.66	8.61	4.80	-1.78
Net Margin (%)	25.56	2.35	14.70	4.46	-8.71
RoE (%)	99.59	7.58	37.85	14.91	-1.56
Price to Earnings	17.25	60.99	11.12	28.45	--
Price-To-Book	--	4.41	2.04	--	0.30

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Operating Revenue	38.20	5,095.78	58.27	106.81	25.48
Total Income	38.33	5,135.29	58.54	107.59	28.21
Total Expenditure	22.82	4,924.23	49.14	98.22	27.28
EBITDA	15.37	171.55	9.13	8.59	-1.80
Depreciation	1.01	30.69	0.20	0.69	1.72
EBIT	14.37	140.86	8.93	7.90	-3.52
Interest	1.35	41.62	0.51	2.15	0.05
Other Income	0.13	39.51	0.27	0.78	2.73
Exceptional Items	--	--	--	--	--
Profit before Tax	13.14	138.74	8.69	6.52	-0.84
Provision for Tax	3.35	31.31	0.08	1.73	-0.27
Profit after Tax	9.79	107.43	8.61	4.80	-0.57

Liabilities (₹ Cr)

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Shareholder's Funds	14.73	1,724.15	30.42	32.17	121.28
Minority Interest	--	46.21	--	--	--
Non-Current Liabilities	7.17	72.84	2.77	0.47	1.05
Current Liabilities	16.99	845.02	6.80	24.46	3.10
Total Liabilities	39.12	2,702.52	39.98	57.15	125.42

Assets (₹ Cr)

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Non-Current Assets	7.81	612.51	3.56	10.70	71.99
Current Assets	31.09	2,075.71	36.42	46.40	53.44
Total Assets	39.12	2,702.52	39.98	57.15	125.42
Total Debt*	15.01	298.81	5.05	21.77	0.00
Net Current Assets	14.10	1,230.69	29.62	21.95	50.34
Contingent Liabilities	0.05	4.01	--	0.39	--

Cashflow (₹ Cr)

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Cash From Operating Activities	-3.67	-76.87	-5.79	-7.89	5.07
Cash Flow from Investing Activities	0.34	219.80	-2.07	-0.55	-4.98
Cash from Financing Activities	3.33	-73.66	8.46	-2.38	--
Net Cash Inflow / Outflow	0.00	69.27	0.60	-10.82	0.09

Ratios

Profitability Ratios

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
ROCE (%)	64.18	9.16	34.47	16.08	-0.66
ROE (%)	99.59	6.40	37.85	14.91	-0.47
ROA (%)	33.60	4.29	27.50	8.40	-0.45
EBIT Margin (%)	40.59	4.14	16.13	8.77	3.63
Net Margin (%)	25.56	2.09	14.70	4.46	-2.02
Cash Profit Margin (%)	28.28	2.71	15.11	5.14	4.50

Growth Ratios

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Revenue Growth (%)	150.47	29.92	111.71	0.00	-6.83
EBIT Growth (%)	170.72	67.16	73.88	--	93.84
Net Profit Growth (%)	292.00	169.94	193.43	0.00	74.52
EPS Growth (%)	292.00	142.37	133.30	0.00	74.52
Book Value Growth (%)	198.35	5.11	101.92	0.00	0.24

Valuation Ratios

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Price / Earnings	0.00	52.15	0.00	0.00	0.00
Price / Book Value	0.00	2.88	0.00	0.00	0.43
Dividend Yield (%)	--	0.00	--	--	0.00
EV/EBITDA	1.56	23.61	1.13	3.49	55.53
Market Cap (₹ Cr)	0.00	4,944.94	0.00	0.00	51.76

Solvency Ratios

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Debt to Equity	1.02	0.17	0.17	0.68	0.00
Short term debt to equity ratio	0.43	0.17	0.04	0.64	--
Current Ratio	1.83	2.46	5.36	1.90	17.25
Quick Ratio	0.76	1.68	2.80	1.43	16.21
Interest Coverage	10.70	4.33	18.03	4.03	-16.63

Operating Efficiency Ratios

	Bio Medica Laboratories	Entero Health	Speciality Medicines	VijayPD Ceutical	Medi-Caps
Debtors to sales (%)	10.73	16.30	16.45	22.28	34.50
Asset Turnover	1.31	2.03	1.86	1.87	0.20
Receivable days	30.75	51.78	63.57	81.32	140.45
Inventory Days	121.86	38.71	79.57	39.42	64.01
Payable days	117.74	24.83	14.65	8.63	63.40
Cash Conversion Cycle	34.88	65.66	128.49	112.12	141.06

Annual
Quarterly